- INSTRUCTOR Medicine, Infectious Diseases
American Board of Internal Medicine
MD, Georgetown University Hospital
Residency, Internal Medicine
Mount Sinai School of Medicine
Fellowship, Infectious Disease
Mount Sinai School of Medicine
Dr. Sullivan is an infectious diseases specialist who focuses on the treatment of infections in patients who have undergone organ transplantation, those being treated for cancer, and those with other immunocompromising conditions. He is available to see patients in the transplant institute and FPA Infectious Diseases clinics.
Sullivan T, Brodginski A, Patel G, Huprikar S. The Role of Secondary Cytomegalovirus Prophylaxis for Kidney and Liver Transplant Recipients. Transplantation. 2014 Sep 9.Sullivan T. Antibiotic overuse and clostridium difficile: a teachable moment. JAMA Intern Med. 2014 Aug;174(8):1219-20
Sullivan T, Reese L, Huprikar S, Lee M. Pulmonary cryptosporidiosis and IRIS: a case report and review. Int J STD AIDS. 2013 Apr;24(4):333-4
Sullivan T, Ben Amor Y. What's in a name? The future of drug-resistant tuberculosis classification. Lancet Infect Dis. 2013 Apr;13(4):373-6
Sullivan T, Ben Amor Y. The Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing World. PLoS Med. 2012; 9(7).Sullivan T, Benjamin CG, Kempf PW, Deeken JF. Cetuximab in the treatment of rheumatoid arthritis. J Clin Rheumatol. 2010 Jan;16(1):32-3.
Sullivan T, Taghian AG. Management of Tubular Carcinoma of the Breast: General Review. Current Medical Literature: Breast Cancer. 2006; 18(3):61-66.Floyd SR, Buchholz TA, Haffty BG, Goldberg S, Niemierko A, Raad RA, Oswald MJ, Sullivan T, Strom EA, Powell SN, Katz A, Taghian AG. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):358-64.
Sullivan T, Raad RA, Goldberg S, Assaad SI, Gadd M, Smith BL, Powell SN, Taghian AG. Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat. 2005 Oct;93(3):199-205.Jagsi R, Raad RA, Goldberg S, Sullivan T, Michaelson J, Powell SN, Taghian AG. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1035-9.
Taghian AG, Abi-Raad R, Assaad SI, Casty A, Ancukiewicz M, Yeh E, Molokhia P, Attia K, Sullivan T, Kuter I, Boucher Y, Powell SN. Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications. J Clin Oncol. 2005 Mar 20;23(9):1951-61
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Sullivan is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
5 East 98th Street Floor 11th
New York, NY 10029